1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
328.19%
Net income growth above 1.5x CSIQ's 15.46%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
-35.01%
Negative yoy D&A while CSIQ is 0.00%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-155.21%
Negative yoy deferred tax while CSIQ stands at 0.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
-7.28%
Negative yoy SBC while CSIQ is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
35.73%
Slight usage while CSIQ is negative at -182.03%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-141.33%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
-131.78%
Negative yoy inventory while CSIQ is 0.00%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
517.38%
AP growth of 517.38% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
59.00%
Growth of 59.00% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
-959.64%
Both negative yoy, with CSIQ at -46.62%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
90.53%
Some CFO growth while CSIQ is negative at -76.59%. John Neff would note a short-term liquidity lead over the competitor.
-8.65%
Negative yoy CapEx while CSIQ is 13.64%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
104.42%
Acquisition growth of 104.42% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
114.62%
Investing outflow well above CSIQ's 18.10%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
61.26%
Buyback growth of 61.26% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.